| GTO ID | GTC3537 |
| Trial ID | NCT05981066 |
| Disease | Hepatocellular Carcinoma |
| Therapy | mRNA vaccine |
| Treatment | ABOR2014|IPM511 |
| Phase | Not Applicable |
| Recruitment status | Recruiting |
| Title | An Open, Single-center, Multiple-dose, Dose-increasing and Dose-expanding Clinical Study to Observe and Evaluate the Safety, Tolerance, Immunokinetics and Preliminary Effectiveness of ABOR2014 Injection (IPM511) in the Treatment of Advanced Hepatocellular Carcinoma |
| Year | 2023 |
| Country | China |
| Company sponsor | Peking Union Medical College Hospital |
| Other ID(s) | J-23PJ957 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||||
|
|||||||||